Prevention
Conditions
Keywords
personalized prevention
Brief summary
Prevention, a cornerstone of public health, remains underutilized despite its proven effectiveness. Vaccinations, screenings, reduced consumption of toxic substances, and healthy lifestyle and dietary habits can significantly reduce morbidity and mortality. However, participation rates in France remain low compared to those of neighboring European countries, particularly with regard to cancer screenings and vaccination coverage. A lack of information, motivation, or unequal access hinders adherence to preventive measures. Some of these factors can be addressed. Emergency departments, although rarely utilized for prevention, serve a diverse population and could serve as a strategic lever for educating the public about preventive health measures. Personalized information, supported by a digital tool, could improve adherence to preventive measures. An interactive questionnaire was developed to tailor the information provided to patients based on their personal characteristics. The information delivered in this way would be more targeted for each patient and more likely to have a positive impact on the implementation of various preventive measures. The purpose of this study is to determine whether a digital tool that provides personalized prevention information is more effective than general, non-personalized information in improving adherence among patients visiting the emergency department to the preventive measures recommended for them.
Interventions
PROCEDUREpersonalized preventive health information
The intervention involves providing personalized preventive health information regarding recommended preventive measures based on age, biological sex, weight, height, bedtime and wake-up times, the presence of chronic conditions, and tobacco or alcohol use.
PROCEDUREnon-personalized preventive health information
The intervention involves providing non-personalized preventive health information. The patient receives all the preventive health information without it being tailored to the patient. The patient therefore does not see any information specific to him or her.
Sponsors
Centre Hospitalier le Mans
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients (≥ 18 years of age) * Patients seen in the emergency departments of Le Mans University Hospital and the PSSL * Patients who have given their free and informed oral consent
Exclusion criteria
* Patients who have previously participated in the study * Patients with limited understanding of the French language * Patients unable to give informed consent * Individuals not enrolled in or not eligible for a social security program * Individuals deprived of their liberty by judicial or administrative order * Individuals receiving involuntary psychiatric care * Individuals subject to a legal protective measure * Pregnant or breastfeeding patients.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| proportion of patients who adhered to at least 25% of the preventive measures | 6-8 weeks after the intervention. | The primary outcome measure is the proportion of patients who adhered to at least 25% of the preventive measures for which they were eligible, as assessed 6-8 weeks after the intervention. Adherence is defined as the completion of a preventive measure or the initiation of steps leading to its completion in the short term |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of patients who adhered to each of the preventive measures studied. | 6-8 weeks after the intervention. |
| The proportion of preventive measures taken by the patient, relative to the measures for which the patient is eligible. | 6-8 weeks after the intervention. |
| The enrollment rate for each epidemiological subgroup (age, sex, whether the patient has a primary care physician, whether the patient has a chronic condition, socioeconomic status). | 6-8 weeks after the intervention. |
Countries
France
Contacts
CONTACTChristelle JADEAU
CONTACTCyrielle HOUALARD, MD
Outcome results
None listed